デフォルト表紙
市場調査レポート
商品コード
1703222

持続的腎代替療法の世界市場レポート 2025年

Continuous Renal Replacement Therapy Global Market Report 2025


出版日
ページ情報
英文 200 Pages
納期
2~10営業日
カスタマイズ可能
適宜更新あり
価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=143.57円
持続的腎代替療法の世界市場レポート 2025年
出版日: 2025年04月01日
発行: The Business Research Company
ページ情報: 英文 200 Pages
納期: 2~10営業日
GIIご利用のメリット
  • 全表示
  • 概要
  • 目次
概要

持続的腎代替療法市場規模は、今後数年で急成長が見込まれます。2029年の年間平均成長率(CAGR)は10.9%で、26億4,000万米ドルに成長します。予測期間の成長は、慢性腎臓病の増加、糖尿病有病率の上昇、ICU入院数の増加、ヘルスケアインフラへの投資増加、小児医療への応用拡大などに起因しています。予測期間の主な動向には、急速な進歩、新技術の発表、技術の進歩、製品の革新、技術的に高度なCRRT製品などがあります。

慢性腎臓病(CKD)の有病率の増加は、今後の持続的腎代替療法(CRRT)市場の拡大を牽引すると予想されます。CKDは、腎機能が徐々に低下し、血液から老廃物をろ過する臓器の能力が損なわれる長期的な状態です。このCKD症例の増加は、ライフスタイルの変化、高齢化、糖尿病や高血圧の罹患率の上昇などの要因によるところが大きいです。持続的腎代替療法は、CKDの急性増悪や合併症の管理に一般的に使用され、体液バランスを調整し、代謝性老廃物を継続的に除去するのに役立ちます。例えば、2024年5月、米国疾病予防管理センター(CDC)は、米国の成人3,550万人以上(約7人に1人)がCKDに罹患していると報告しました。驚くべきことに、これらの人々の90%近くが自分の病状に気づいておらず、米国における早期発見と啓蒙活動には大きな隔たりがあることを浮き彫りにしています。

持続的腎代替療法(CRRT)市場の主要企業は、透析患者のための先進的な腎療法ソリューションの開発に注力しており、治療効果の改善、患者の予後の向上、従来の透析法に関連する合併症の軽減を目指しています。従来の透析とは異なり、この療法は連続的(通常は24時間)に行われ、身体に優しいため、特に急性腎障害や重篤な病状の患者に適しています。たとえば、2023年1月、米国を拠点に救急および外科サービスを提供するヘルスケア施設であるペコニック・ベイ・メディカル・センター(PBMC)は、透析患者に新しい腎療法オプションを導入しました。この治療法は、健康状態によって標準的な透析に耐えられない患者にも、より快適な透析を提供できるように設計されています。CRRTは従来の透析よりも徐々に実施されるため、重症患者のストレス軽減に役立ちます。

目次

第1章 エグゼクティブサマリー

第2章 市場の特徴

第3章 市場動向と戦略

第4章 市場- 金利、インフレ、地政学、新型コロナウイルス感染症、そして景気回復が市場に与える影響を含むマクロ経済シナリオ

第5章 世界の成長分析と戦略分析フレームワーク

  • 世界持続的腎代替療法PESTEL分析(政治、社会、技術、環境、法的要因、促進要因と抑制要因)
  • 最終用途産業の分析
  • 世界の持続的腎代替療法市場:成長率分析
  • 世界の持続的腎代替療法市場の実績:規模と成長, 2019-2024
  • 世界の持続的腎代替療法市場の予測:規模と成長, 2024-2029, 2034F
  • 世界持続的腎代替療法総アドレス可能市場(TAM)

第6章 市場セグメンテーション

  • 世界の持続的腎代替療法市場:製品別、実績と予測, 2019-2024, 2024-2029F, 2034F
  • システム
  • 消耗品
  • 世界の持続的腎代替療法市場セラピーによって、実績と予測, 2019-2024, 2024-2029F, 2034F
  • 腎臓
  • 非腎臓
  • 世界の持続的腎代替療法市場:モダリティ別、実績と予測, 2019-2024, 2024-2029F, 2034F
  • 低速連続限外濾過(SCUF)
  • 持続的静脈血液濾過(CVVH)
  • 持続静脈血液透析(CVVHD)
  • 持続的静脈血液濾過透析(CVVHDF)
  • 世界の持続的腎代替療法市場:年齢層別、実績と予測, 2019-2024, 2024-2029F, 2034F
  • 大人
  • 小児科または新生児科
  • 世界の持続的腎代替療法市場:エンドユーザー別、実績と予測, 2019-2024, 2024-2029F, 2034F
  • 病院
  • 外来診療
  • ホームケア
  • 世界の持続的腎代替療法市場、システムのサブセグメンテーション、タイプ別、実績と予測, 2019-2024, 2024-2029F, 2034F
  • 血液濾過器
  • CRRTマシン
  • 血液チューブセット
  • 世界の持続的腎代替療法市場消耗品の種類別サブセグメンテーション、実績と予測, 2019-2024, 2024-2029F, 2034F
  • 透析液
  • 補充液
  • カテーテル
  • 血統セット

第7章 地域別・国別分析

  • 世界の持続的腎代替療法市場:地域別、実績と予測, 2019-2024, 2024-2029F, 2034F
  • 世界の持続的腎代替療法市場:国別、実績と予測, 2019-2024, 2024-2029F, 2034F

第8章 アジア太平洋市場

第9章 中国市場

第10章 インド市場

第11章 日本市場

第12章 オーストラリア市場

第13章 インドネシア市場

第14章 韓国市場

第15章 西欧市場

第16章 英国市場

第17章 ドイツ市場

第18章 フランス市場

第19章 イタリア市場

第20章 スペイン市場

第21章 東欧市場

第22章 ロシア市場

第23章 北米市場

第24章 米国市場

第25章 カナダ市場

第26章 南米市場

第27章 ブラジル市場

第28章 中東市場

第29章 アフリカ市場

第30章 競合情勢と企業プロファイル

  • 持続的腎代替療法市場:競合情勢
  • 持続的腎代替療法市場:企業プロファイル
    • Medtronic Plc Overview, Products and Services, Strategy and Financial Analysis
    • Fresenius Medical Care AG & Co. KGaA Overview, Products and Services, Strategy and Financial Analysis
    • Asahi Kasei Corporation Overview, Products and Services, Strategy and Financial Analysis
    • Toray Industries Inc. Overview, Products and Services, Strategy and Financial Analysis
    • Baxter International Inc. Overview, Products and Services, Strategy and Financial Analysis

第31章 その他の大手企業と革新的企業

  • B. Braun Melsungen AG
  • Terumo Corporation
  • Nipro Corporation
  • NxStage Medical Inc.
  • Hillrom Holdings Inc.
  • Gambro AB
  • JMS Co. Ltd.
  • Quanta Dialysis Technologies Ltd.
  • Bellco S.r.l.
  • Ningbo Tianyi Medical Devices Co. Ltd.
  • Cytosorbents Corporation
  • Kawasumi Laboratories Inc.
  • Medica S.p.A.
  • Infomed SA
  • Medites Pharma Spol. S.R.O

第32章 世界の市場競合ベンチマーキングとダッシュボード

第33章 主要な合併と買収

第34章 最近の市場動向

第35章 市場の潜在力が高い国、セグメント、戦略

  • 持続的腎代替療法市場2029:新たな機会を提供する国
  • 持続的腎代替療法市場2029:新たな機会を提供するセグメント
  • 持続的腎代替療法市場2029:成長戦略
    • 市場動向に基づく戦略
    • 競合の戦略

第36章 付録

目次
Product Code: r29883

Continuous renal replacement therapy (CRRT) is a form of dialysis that provides gradual, ongoing blood filtration to help regulate levels of fluids, electrolytes, and waste products in critically ill patients with acute kidney injury (AKI) who are hemodynamically unstable. It plays a crucial role in managing fluid overload in critically ill patients, particularly those who cannot tolerate rapid fluid removal through intermittent hemodialysis due to cardiovascular instability.

The primary products in the continuous renal replacement therapy market are systems and consumables. A continuous renal replacement therapy (CRRT) system is a specialized medical device utilized in treating critically ill patients with AKI or other renal conditions. It offers various renal and non-renal therapies using different modalities such as slow continuous ultrafiltration (SCUF), continuous venovenous hemofiltration (CVVH), continuous venovenous hemodialysis (CVVHD), and continuous venovenous hemodiafiltration (CVVHDF). These therapies are administered to adults, pediatrics, and neonates in various settings including hospitals, ambulatory care centers, and homecare setups.

The continuous renal replacement therapy market research report is one of a series of new reports from The Business Research Company that provides continuous renal replacement therapy market statistics, including continuous renal replacement therapy industry global market size, regional shares, competitors with a continuous renal replacement therapy market share, detailed continuous renal replacement therapy market segments, market trends and opportunities, and any further data you may need to thrive in the continuous renal replacement therapy industry. This continuous renal replacement therapy market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The continuous renal replacement therapy market size has grown rapidly in recent years. It will grow from $1.57 billion in 2024 to $1.74 billion in 2025 at a compound annual growth rate (CAGR) of 11.3%. The growth in the historic period can be attributed to increased demand for advanced CRRT devices, an increase in the prevalence of incidence of acute kidney injury, a rise in the number of medical applications, a high prevalence of co-morbidities, and continuous research and development.

The continuous renal replacement therapy market size is expected to see rapid growth in the next few years. It will grow to $2.64 billion in 2029 at a compound annual growth rate (CAGR) of 10.9%. The growth in the forecast period can be attributed to increasing incidences of chronic kidney diseases, rising prevalence of diabetes, a growing number of ICU admissions, rising investments in healthcare infrastructure, and expanding applications in pediatric care. Major trends in the forecast period include rapid advancements, launches of new technologies, technological advancements, product innovation, and technologically advanced CRRT products.

The growing prevalence of chronic kidney disease (CKD) is expected to drive the expansion of the continuous renal replacement therapy (CRRT) market in the future. CKD is a long-term condition in which kidney function gradually declines, impairing the organ's ability to filter waste from the blood. This increase in CKD cases is largely attributed to factors such as lifestyle changes, an aging population, and higher rates of diabetes and hypertension. Continuous renal replacement therapy is commonly used to manage acute exacerbations or complications of CKD, helping to regulate fluid balance and remove metabolic waste continuously. For example, in May 2024, the Centers for Disease Control and Prevention (CDC) reported that more than 35.5 million adults in the United States-about 1 in 7-are affected by CKD. Alarmingly, nearly 90% of these individuals are unaware of their condition, highlighting the significant gap in early detection and awareness efforts in the U.S.

Leading companies in the continuous renal replacement therapy (CRRT) market are concentrating on developing advanced renal therapy solutions for dialysis patients, aiming to improve treatment effectiveness, enhance patient outcomes, and reduce complications linked to conventional dialysis methods. Unlike traditional dialysis, this therapy runs continuously-usually over a 24-hour period-and is gentler on the body, making it particularly suitable for patients with acute kidney injuries or severe medical conditions. For example, in January 2023, Peconic Bay Medical Center (PBMC), a U.S.-based healthcare facility offering emergency and surgical services, introduced a new renal therapy option for dialysis patients. This therapy is designed to offer greater comfort to patients who may not tolerate standard dialysis due to their health conditions. CRRT is administered more gradually than traditional dialysis, which helps reduce stress on critically ill patients.

In August 2024, Baxter International Inc., a U.S.-based healthcare company known for producing medical products, acquired The Carlyle Group Inc. for $3.8 billion. This acquisition allows Carlyle Group to strengthen its portfolio in renal care, positioning itself to capitalize on the increasing demand for innovative dialysis products and services for patients with chronic kidney disease. The Carlyle Group Inc. is a U.S.-based investment firm with a focus on continuous renal replacement therapy.

Major companies operating in the continuous renal replacement therapy market are Medtronic Plc, Fresenius Medical Care AG & Co. KGaA, Asahi Kasei Corporation, Toray Industries Inc., Baxter International Inc., B. Braun Melsungen AG, Terumo Corporation, Nipro Corporation, NxStage Medical Inc., Hillrom Holdings Inc., Gambro AB, JMS Co. Ltd., Quanta Dialysis Technologies Ltd., Bellco S.r.l., Ningbo Tianyi Medical Devices Co. Ltd., Cytosorbents Corporation, Kawasumi Laboratories Inc., Medica S.p.A., Infomed SA, Medites Pharma Spol. S.R.O, Nikkiso Co. Ltd., Anjue Medical Equipment Co. Ltd., Medcomp Systems Ltd.

North America was the largest region in the continuous renal replacement therapy market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the continuous renal replacement therapy market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.

The countries covered in the continuous renal replacement therapy market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain

The continuous renal replacement therapy (CRRT) market consists of revenues earned by entities by providing services such as acute hemodialysis, aquapheresis, and fluid management. The market value includes the value of related goods sold by the service provider or included within the service offering. The continuous renal replacement therapy market also includes sales of dialysis catheters, dialysates, hemostatic agents, and airway clearance systems. Values in this market are 'factory gate' values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Continuous Renal Replacement Therapy Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on continuous renal replacement therapy market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

  • Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
  • Assess the impact of key macro factors such as conflict, pandemic and recovery, inflation and interest rate environment and the 2nd Trump presidency.
  • Create regional and country strategies on the basis of local data and analysis.
  • Identify growth segments for investment.
  • Outperform competitors using forecast data and the drivers and trends shaping the market.
  • Understand customers based on the latest market shares.
  • Benchmark performance against key competitors.
  • Suitable for supporting your internal and external presentations with reliable high quality data and analysis
  • Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
  • All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for continuous renal replacement therapy ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The continuous renal replacement therapy market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

  • The market characteristics section of the report defines and explains the market.
  • The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
  • The forecasts are made after considering the major factors currently impacting the market. These include:

The forecasts are made after considering the major factors currently impacting the market. These include the Russia-Ukraine war, rising inflation, higher interest rates, and the legacy of the COVID-19 pandemic.

  • Market segmentations break down the market into sub markets.
  • The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth. It covers the growth trajectory of COVID-19 for all regions, key developed countries and major emerging markets.
  • The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
  • The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.

Scope

  • Markets Covered:1) By Product: System; Consumables
  • 2) By Therapy: Renal; Non-Renal
  • 3) By Modality: Slow Continuous Ultra-Filtration (SCUF); Continuous Venovenous Hemofiltration (CVVH); Continuous Venovenous Hemodialysis (CVVHD); Continuous Venovenous Hemodiafiltration (CVVHDF)
  • 4) By Age Group: Adults; Pediatrics Or Neonates
  • 5) By End-Users: Hospitals; Ambulatory Care; Homecare
  • Subsegments:
  • 1) By System: Hemofilters; CRRT Machines; Blood Tubing Sets
  • 2) By Consumables: Dialysate Solutions; Replacement Fluids; Catheters; Bloodline Sets
  • Companies Mentioned: Medtronic Plc; Fresenius Medical Care AG & Co. KGaA; Asahi Kasei Corporation; Toray Industries Inc.; Baxter International Inc.
  • Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain
  • Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
  • Time series: Five years historic and ten years forecast.
  • Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
  • Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.
  • Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
  • Delivery format: PDF, Word and Excel Data Dashboard.

Table of Contents

1. Executive Summary

2. Continuous Renal Replacement Therapy Market Characteristics

3. Continuous Renal Replacement Therapy Market Trends And Strategies

4. Continuous Renal Replacement Therapy Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Covid And Recovery On The Market

5. Global Continuous Renal Replacement Therapy Growth Analysis And Strategic Analysis Framework

  • 5.1. Global Continuous Renal Replacement Therapy PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
  • 5.2. Analysis Of End Use Industries
  • 5.3. Global Continuous Renal Replacement Therapy Market Growth Rate Analysis
  • 5.4. Global Continuous Renal Replacement Therapy Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)
  • 5.5. Global Continuous Renal Replacement Therapy Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)
  • 5.6. Global Continuous Renal Replacement Therapy Total Addressable Market (TAM)

6. Continuous Renal Replacement Therapy Market Segmentation

  • 6.1. Global Continuous Renal Replacement Therapy Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • System
  • Consumables
  • 6.2. Global Continuous Renal Replacement Therapy Market, Segmentation By Therapy, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Renal
  • Non-Renal
  • 6.3. Global Continuous Renal Replacement Therapy Market, Segmentation By Modality, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Slow Continuous Ultra-Filtration (SCUF)
  • Continuous Venovenous Hemofiltration (CVVH)
  • Continuous Venovenous Hemodialysis (CVVHD)
  • Continuous Venovenous Hemodiafiltration (CVVHDF)
  • 6.4. Global Continuous Renal Replacement Therapy Market, Segmentation By Age Group, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Adults
  • Pediatrics Or Neonates
  • 6.5. Global Continuous Renal Replacement Therapy Market, Segmentation By End-Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Hospitals
  • Ambulatory Care
  • Homecare
  • 6.6. Global Continuous Renal Replacement Therapy Market, Sub-Segmentation Of System, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Hemofilters
  • CRRT Machines
  • Blood Tubing Sets
  • 6.7. Global Continuous Renal Replacement Therapy Market, Sub-Segmentation Of Consumables, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Dialysate Solutions
  • Replacement Fluids
  • Catheters
  • Bloodline Sets

7. Continuous Renal Replacement Therapy Market Regional And Country Analysis

  • 7.1. Global Continuous Renal Replacement Therapy Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 7.2. Global Continuous Renal Replacement Therapy Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8. Asia-Pacific Continuous Renal Replacement Therapy Market

  • 8.1. Asia-Pacific Continuous Renal Replacement Therapy Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 8.2. Asia-Pacific Continuous Renal Replacement Therapy Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 8.3. Asia-Pacific Continuous Renal Replacement Therapy Market, Segmentation By Therapy, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 8.4. Asia-Pacific Continuous Renal Replacement Therapy Market, Segmentation By Modality, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

9. China Continuous Renal Replacement Therapy Market

  • 9.1. China Continuous Renal Replacement Therapy Market Overview
  • 9.2. China Continuous Renal Replacement Therapy Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
  • 9.3. China Continuous Renal Replacement Therapy Market, Segmentation By Therapy, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
  • 9.4. China Continuous Renal Replacement Therapy Market, Segmentation By Modality, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

10. India Continuous Renal Replacement Therapy Market

  • 10.1. India Continuous Renal Replacement Therapy Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 10.2. India Continuous Renal Replacement Therapy Market, Segmentation By Therapy, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 10.3. India Continuous Renal Replacement Therapy Market, Segmentation By Modality, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11. Japan Continuous Renal Replacement Therapy Market

  • 11.1. Japan Continuous Renal Replacement Therapy Market Overview
  • 11.2. Japan Continuous Renal Replacement Therapy Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 11.3. Japan Continuous Renal Replacement Therapy Market, Segmentation By Therapy, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 11.4. Japan Continuous Renal Replacement Therapy Market, Segmentation By Modality, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12. Australia Continuous Renal Replacement Therapy Market

  • 12.1. Australia Continuous Renal Replacement Therapy Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 12.2. Australia Continuous Renal Replacement Therapy Market, Segmentation By Therapy, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 12.3. Australia Continuous Renal Replacement Therapy Market, Segmentation By Modality, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13. Indonesia Continuous Renal Replacement Therapy Market

  • 13.1. Indonesia Continuous Renal Replacement Therapy Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 13.2. Indonesia Continuous Renal Replacement Therapy Market, Segmentation By Therapy, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 13.3. Indonesia Continuous Renal Replacement Therapy Market, Segmentation By Modality, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14. South Korea Continuous Renal Replacement Therapy Market

  • 14.1. South Korea Continuous Renal Replacement Therapy Market Overview
  • 14.2. South Korea Continuous Renal Replacement Therapy Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 14.3. South Korea Continuous Renal Replacement Therapy Market, Segmentation By Therapy, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 14.4. South Korea Continuous Renal Replacement Therapy Market, Segmentation By Modality, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15. Western Europe Continuous Renal Replacement Therapy Market

  • 15.1. Western Europe Continuous Renal Replacement Therapy Market Overview
  • 15.2. Western Europe Continuous Renal Replacement Therapy Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 15.3. Western Europe Continuous Renal Replacement Therapy Market, Segmentation By Therapy, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 15.4. Western Europe Continuous Renal Replacement Therapy Market, Segmentation By Modality, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16. UK Continuous Renal Replacement Therapy Market

  • 16.1. UK Continuous Renal Replacement Therapy Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 16.2. UK Continuous Renal Replacement Therapy Market, Segmentation By Therapy, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 16.3. UK Continuous Renal Replacement Therapy Market, Segmentation By Modality, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17. Germany Continuous Renal Replacement Therapy Market

  • 17.1. Germany Continuous Renal Replacement Therapy Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 17.2. Germany Continuous Renal Replacement Therapy Market, Segmentation By Therapy, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 17.3. Germany Continuous Renal Replacement Therapy Market, Segmentation By Modality, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18. France Continuous Renal Replacement Therapy Market

  • 18.1. France Continuous Renal Replacement Therapy Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 18.2. France Continuous Renal Replacement Therapy Market, Segmentation By Therapy, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 18.3. France Continuous Renal Replacement Therapy Market, Segmentation By Modality, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19. Italy Continuous Renal Replacement Therapy Market

  • 19.1. Italy Continuous Renal Replacement Therapy Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 19.2. Italy Continuous Renal Replacement Therapy Market, Segmentation By Therapy, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 19.3. Italy Continuous Renal Replacement Therapy Market, Segmentation By Modality, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20. Spain Continuous Renal Replacement Therapy Market

  • 20.1. Spain Continuous Renal Replacement Therapy Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 20.2. Spain Continuous Renal Replacement Therapy Market, Segmentation By Therapy, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 20.3. Spain Continuous Renal Replacement Therapy Market, Segmentation By Modality, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21. Eastern Europe Continuous Renal Replacement Therapy Market

  • 21.1. Eastern Europe Continuous Renal Replacement Therapy Market Overview
  • 21.2. Eastern Europe Continuous Renal Replacement Therapy Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 21.3. Eastern Europe Continuous Renal Replacement Therapy Market, Segmentation By Therapy, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 21.4. Eastern Europe Continuous Renal Replacement Therapy Market, Segmentation By Modality, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22. Russia Continuous Renal Replacement Therapy Market

  • 22.1. Russia Continuous Renal Replacement Therapy Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 22.2. Russia Continuous Renal Replacement Therapy Market, Segmentation By Therapy, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 22.3. Russia Continuous Renal Replacement Therapy Market, Segmentation By Modality, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23. North America Continuous Renal Replacement Therapy Market

  • 23.1. North America Continuous Renal Replacement Therapy Market Overview
  • 23.2. North America Continuous Renal Replacement Therapy Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 23.3. North America Continuous Renal Replacement Therapy Market, Segmentation By Therapy, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 23.4. North America Continuous Renal Replacement Therapy Market, Segmentation By Modality, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24. USA Continuous Renal Replacement Therapy Market

  • 24.1. USA Continuous Renal Replacement Therapy Market Overview
  • 24.2. USA Continuous Renal Replacement Therapy Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 24.3. USA Continuous Renal Replacement Therapy Market, Segmentation By Therapy, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 24.4. USA Continuous Renal Replacement Therapy Market, Segmentation By Modality, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25. Canada Continuous Renal Replacement Therapy Market

  • 25.1. Canada Continuous Renal Replacement Therapy Market Overview
  • 25.2. Canada Continuous Renal Replacement Therapy Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 25.3. Canada Continuous Renal Replacement Therapy Market, Segmentation By Therapy, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 25.4. Canada Continuous Renal Replacement Therapy Market, Segmentation By Modality, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26. South America Continuous Renal Replacement Therapy Market

  • 26.1. South America Continuous Renal Replacement Therapy Market Overview
  • 26.2. South America Continuous Renal Replacement Therapy Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 26.3. South America Continuous Renal Replacement Therapy Market, Segmentation By Therapy, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 26.4. South America Continuous Renal Replacement Therapy Market, Segmentation By Modality, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27. Brazil Continuous Renal Replacement Therapy Market

  • 27.1. Brazil Continuous Renal Replacement Therapy Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 27.2. Brazil Continuous Renal Replacement Therapy Market, Segmentation By Therapy, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 27.3. Brazil Continuous Renal Replacement Therapy Market, Segmentation By Modality, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28. Middle East Continuous Renal Replacement Therapy Market

  • 28.1. Middle East Continuous Renal Replacement Therapy Market Overview
  • 28.2. Middle East Continuous Renal Replacement Therapy Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 28.3. Middle East Continuous Renal Replacement Therapy Market, Segmentation By Therapy, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 28.4. Middle East Continuous Renal Replacement Therapy Market, Segmentation By Modality, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29. Africa Continuous Renal Replacement Therapy Market

  • 29.1. Africa Continuous Renal Replacement Therapy Market Overview
  • 29.2. Africa Continuous Renal Replacement Therapy Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 29.3. Africa Continuous Renal Replacement Therapy Market, Segmentation By Therapy, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 29.4. Africa Continuous Renal Replacement Therapy Market, Segmentation By Modality, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

30. Continuous Renal Replacement Therapy Market Competitive Landscape And Company Profiles

  • 30.1. Continuous Renal Replacement Therapy Market Competitive Landscape
  • 30.2. Continuous Renal Replacement Therapy Market Company Profiles
    • 30.2.1. Medtronic Plc Overview, Products and Services, Strategy and Financial Analysis
    • 30.2.2. Fresenius Medical Care AG & Co. KGaA Overview, Products and Services, Strategy and Financial Analysis
    • 30.2.3. Asahi Kasei Corporation Overview, Products and Services, Strategy and Financial Analysis
    • 30.2.4. Toray Industries Inc. Overview, Products and Services, Strategy and Financial Analysis
    • 30.2.5. Baxter International Inc. Overview, Products and Services, Strategy and Financial Analysis

31. Continuous Renal Replacement Therapy Market Other Major And Innovative Companies

  • 31.1. B. Braun Melsungen AG
  • 31.2. Terumo Corporation
  • 31.3. Nipro Corporation
  • 31.4. NxStage Medical Inc.
  • 31.5. Hillrom Holdings Inc.
  • 31.6. Gambro AB
  • 31.7. JMS Co. Ltd.
  • 31.8. Quanta Dialysis Technologies Ltd.
  • 31.9. Bellco S.r.l.
  • 31.10. Ningbo Tianyi Medical Devices Co. Ltd.
  • 31.11. Cytosorbents Corporation
  • 31.12. Kawasumi Laboratories Inc.
  • 31.13. Medica S.p.A.
  • 31.14. Infomed SA
  • 31.15. Medites Pharma Spol. S.R.O

32. Global Continuous Renal Replacement Therapy Market Competitive Benchmarking And Dashboard

33. Key Mergers And Acquisitions In The Continuous Renal Replacement Therapy Market

34. Recent Developments In The Continuous Renal Replacement Therapy Market

35. Continuous Renal Replacement Therapy Market High Potential Countries, Segments and Strategies

  • 35.1 Continuous Renal Replacement Therapy Market In 2029 - Countries Offering Most New Opportunities
  • 35.2 Continuous Renal Replacement Therapy Market In 2029 - Segments Offering Most New Opportunities
  • 35.3 Continuous Renal Replacement Therapy Market In 2029 - Growth Strategies
    • 35.3.1 Market Trend Based Strategies
    • 35.3.2 Competitor Strategies

36. Appendix

  • 36.1. Abbreviations
  • 36.2. Currencies
  • 36.3. Historic And Forecast Inflation Rates
  • 36.4. Research Inquiries
  • 36.5. The Business Research Company
  • 36.6. Copyright And Disclaimer